• OPEN AN ACCOUNT
Indian Indices
Sensex
81,537.70 -769.67
( -0.94%)
Global Indices
Nasdaq
49,128.98 -276.04
(-0.56%)
Dow Jones
6,938.97 4.62
(0.07%)
Hang Seng
53,831.56 142.67
(0.27%)
Nikkei 225
10,138.52 -11.53
(-0.11%)
Forex
USD-INR
91.58 0.09
(0.10%)
EUR-INR
107.27 0.14
(0.13%)
GBP-INR
123.20 0.33
(0.27%)
JPY-INR
0.58 0.00
(-0.17%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
205.5515954
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
39.16
773.38
EPS(TTM)
Face Value()
Div & Yield %
16.76
10
0.23
 

Artson reports standalone net loss of Rs 2.24 crore in the September 2025 quarter
Oct 17,2025
Net Loss of Artson reported to Rs 2.24 crore in the quarter ended September 2025 as against net loss of Rs 3.00 crore during the previous quarter ended September 2024. Sales rose 146.64% to Rs 48.12 crore in the quarter ended September 2025 as against Rs 19.51 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales48.1219.51 147
OPM %-0.06-8.15 -
PBDT-2.38-3.53 33
PBT-3.04-4.16 27
NP-2.24-3.00 25